Table 4.
The Val Allele Homozygotes of ABCG2 Val12Met, Compared With the Met Allele Carriers Are Associated With Increased Risk of Incident Ischemic Stroke in Both White and Black Participants of CHS
| ABCG2 Genotype | Events, n | Total, n | Model 1* |
Model 2* |
|||
|---|---|---|---|---|---|---|---|
| HR (90% CI) | P | HR (90% CI) | P | ||||
| White | ValVal | 370 | 3398 | 1.58 (1.12–2.23) | 0.02 | 1.50 (1.06–2.12) | 0.03 |
| ValMet+MetMet | 24 | 335 | 1 (Reference) | 1 (Reference) | |||
| ValMet | 23 | 321 | |||||
| MetMet | 1 | 14 | |||||
| Black | ValVal | 66 | 592 | 3.80 (1.16–12.4) | 0.03 | 3.62 (1.11–11.9) | 0.04 |
| ValMet+MetMet | 2 | 70 | 1 (Reference) | 1 (Reference) | |||
| ValMet | 2 | 69 | |||||
| MetMet | 0 | 1 | |||||
Model 1 was adjusted for baseline age and sex. Model 2 was adjusted for baseline age, sex, body mass index, current smoking, diabetes, impaired fasting glucose, hypertension, LDL cholesterol, and HDL cholesterol.